Dengue - 75 Studies Found Recruiting : Studies on the Pathogen, Vector Control and Clinical Treatment of Dengue Fever in Guangzhou : Dengue Fever : 2015-10-11 Completed : Adult Dengue Platelet Study : Dengue Fever : 2009-11-03 : Procedure: Platelet transfusion Completed : A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children : Dengue Fever : 2006-10-04 : Biological: Dengue Vaccine Formulation 17 Active, not recruiting : A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) : Dengue Fever : 2012-10-04 : Biological: Biological/Vaccine: 4 µg TDENV-PIV with Alum adjuvant Active, not recruiting : A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults : Dengue Fever : 2012-08-08 : Biological: 4 µg TDENV-PIV with Alum adjuvant Completed : Laboratory Diagnosis and Prognosis of Severe Dengue : Dengue Fever : 2011-08-22 Completed : Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults : Dengue Fever : 2004-08-17 : Biological: rDEN1delta30 Live Completed : Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults : Dengue Fever : 2004-10-21 : Biological: rDEN2/4delta30(ME) Vaccine Completed : Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults : Dengue Fever : 2005-12-27 : Biological: rDEN4delta30-200,201 Completed : Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31‐7164) in Healthy Adults : Dengue Fever : 2009-01-27 : Biological: rDEN3delta30/31‐7164 A live attenuated, recombinant DEN3 candidate vaccine virus <<< Previous | Next >>>